Enanta Long Term Debt from 2010 to 2024

ENTA Stock  USD 11.93  0.10  0.83%   
Enanta Pharmaceuticals' Long Term Debt is increasing over the years with slightly volatile fluctuation. Overall, Long Term Debt is expected to go to about 2 M this year. Long Term Debt is debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years. View All Fundamentals
 
Long Term Debt  
First Reported
2013-03-31
Previous Quarter
1.6 M
Current Value
1.6 M
Quarterly Volatility
673.4 K
 
Yuan Drop
 
Covid
Check Enanta Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Enanta main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.9 M, Interest Expense of 3.1 M or Selling General Administrative of 63.9 M, as well as many exotic indicators such as Price To Sales Ratio of 2.53, Dividend Yield of 0.0 or PTB Ratio of 1.92. Enanta financial statements analysis is a perfect complement when working with Enanta Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement Enanta Pharmaceuticals' financial leverage analysis and stock options assessment as well as various Enanta Pharmaceuticals Technical models . Check out the analysis of Enanta Pharmaceuticals Correlation against competitors.
For information on how to trade Enanta Stock refer to our How to Trade Enanta Stock guide.

Latest Enanta Pharmaceuticals' Long Term Debt Growth Pattern

Below is the plot of the Long Term Debt of Enanta Pharmaceuticals over the last few years. Long-term debt is a debt that Enanta Pharmaceuticals has held for over one year. Long-term debt appears on Enanta Pharmaceuticals balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Enanta Pharmaceuticals balance sheet is the sum of the balances of all categories of long-term debt. It is debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years. Enanta Pharmaceuticals' Long Term Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Enanta Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Long Term Debt10 Years Trend
Slightly volatile
   Long Term Debt   
       Timeline  

Enanta Long Term Debt Regression Statistics

Arithmetic Mean979,334
Geometric Mean0.00
Coefficient Of Variation84.19
Mean Deviation769,512
Median1,628,000
Standard Deviation824,531
Sample Variance679.9B
Range2M
R-Value0.93
Mean Square Error103.3B
R-Squared0.86
Slope170,875
Total Sum of Squares9.5T

Enanta Long Term Debt History

2024M
20231.9 M
20171.6 M
2016762 K
2015159 K
2014163 K

Other Fundumenentals of Enanta Pharmaceuticals

Enanta Pharmaceuticals Long Term Debt component correlations

About Enanta Pharmaceuticals Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Enanta Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Enanta Pharmaceuticals investors use historical funamental indicators, such as Enanta Pharmaceuticals's Long Term Debt, to determine how well the company is positioned to perform in the future. Although Enanta Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Enanta Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Enanta Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Enanta Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Enanta Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Long Term Debt1.9 MM
Short and Long Term Debt Total30.5 M32 M
Short and Long Term Debt1.4 M790.1 K
Long Term Debt Total2.1 M1.4 M
Long Term Debt To Capitalization 0.08  0.08 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Enanta Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Enanta Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Enanta Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Enanta Pharmaceuticals Stock:
Check out the analysis of Enanta Pharmaceuticals Correlation against competitors.
For information on how to trade Enanta Stock refer to our How to Trade Enanta Stock guide.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Complementary Tools for Enanta Stock analysis

When running Enanta Pharmaceuticals' price analysis, check to measure Enanta Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enanta Pharmaceuticals is operating at the current time. Most of Enanta Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Enanta Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enanta Pharmaceuticals' price. Additionally, you may evaluate how the addition of Enanta Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Transaction History
View history of all your transactions and understand their impact on performance
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Is Enanta Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enanta Pharmaceuticals. If investors know Enanta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enanta Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.66)
Earnings Share
(6.20)
Revenue Per Share
3.455
Quarterly Revenue Growth
(0.04)
Return On Assets
(0.23)
The market value of Enanta Pharmaceuticals is measured differently than its book value, which is the value of Enanta that is recorded on the company's balance sheet. Investors also form their own opinion of Enanta Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Enanta Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enanta Pharmaceuticals' market value can be influenced by many factors that don't directly affect Enanta Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enanta Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Enanta Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enanta Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.